Back
ProShares Ultra Nasdaq Cloud Computing Vs. Kymera Therapeutics Industry Stock Comparison
Buy
57
SKYU
ProShares Ultra Nasdaq Cloud Computing
Last Price:
$32.43
Seasonality Move:
-3.57%
Buy
58
KYMR
Kymera Therapeutics
Last Price:
$44.92
Seasonality Move:
5.78%
Buy
57
ProShares Ultra Nasdaq Cloud Computing (SKYU)
is a Buy
Is ProShares Ultra Nasdaq Cloud Computing a Buy, Sell or Hold?
-
The current ProShares Ultra Nasdaq Cloud Computing [SKYU] share price is $32.81. The Score for SKYU is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SKYU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $44.90. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SKYU Stock Price Chart
What is ProShares Ultra Nasdaq Cloud Computing's stock price today?
-
The ProShares Ultra Nasdaq Cloud Computing share price today is $32.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKYU is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
SKYU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.21 | Buy |
Relative Strength Index (14 RSI): | 51.98 | Buy |
Chaikin Money Flow: | 500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.04 | Buy |
Relative Strength Index (14 RSI): | 56.78 | Buy |
Chaikin Money Flow: | -176499 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.38 - 47.28) | Sell |
Bollinger Bands (100): | (27.35 - 42.63) | Buy |
SKYU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.78 | Sell |
20-day SMA: | 32.74 | Buy |
50-day SMA: | 31.27 | Buy |
200-day SMA: | 32.5 | Buy |
8-day EMA: | 23.81 | Buy |
20-day EMA: | 13.17 | Buy |
50-day EMA: | 6.07 | Buy |
200-day EMA: | 1.64 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.54 | Buy |
20-day SMA: | 45.33 | Sell |
50-day SMA: | 39.36 | Buy |
200-day SMA: | 39.49 | Buy |
8-day EMA: | 32 | Buy |
20-day EMA: | 17.59 | Buy |
50-day EMA: | 8.1 | Buy |
200-day EMA: | 2.18 | Buy |
ProShares Ultra Nasdaq Cloud Computing Earnings Growth & SKYU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.
ProShares Ultra Nasdaq Cloud Computing Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |